In vitro and in silico cholinesterase inhibitory activities of aaptamine and derivatives from Aaptos suberitoides

Context: Marine sponges from the genus Aaptos produce compounds, often alkaloids, with a wide range of bioactivities. Aaptos suberitoides exhibits anticancer, antioxidant, antibacterial proteasome inhibitory, and receptor activator of NF-kappaB ligand (RANKL) inhibitory activities. Alkaloids from marine sponges have shown potency as cholinesterase inhibitors, one of the targets in Alzheimer’s disease treatment. Aims: To isolate, identify, and investigate the potency of alkaloids from the water fraction of marine sponge A. suberitoides as cholinesterase inhibitors. Methods: Bioassay-guided isolation was employed to obtain active alkaloids. The cholinesterase inhibitory assay was conducted based on Ellman’s method with slight modification. Identification of isolated compounds was carried out based on NMR and MS data. The identified compounds were also subjected to molecular docking analysis as well as an ADMET study. Results: Bioassay-guided isolation of water fraction yielded aaptamine (1) and a mixture containing five benzo[de][1,6]-naphthyridine derivatives, identified based on NMR and LC-MS/MS spectroscopy. Aaptamine (1) inhibited both acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) with IC50 values of 0.23 and 1.38 µg/mL, respectively. Likewise, the benzo[de][1,6]-naphthyridine mixture of N-demethylaaptanone (2), aaptanone (3), demethylaaptamine (4), aaptosine (5) and 8,9,9-trimethoxy-9H-benzo[de][1,6]-naphthyridine (6) recorded IC50 values of 0.39 and 1.61 µg/mL, respectively. Computational molecular docking analysis calculated the S-score and RMSD values of aaptamine (1) to be the best compared to galantamine for both AChE (PBD: 4EY6) and BChE (PDB: 4BDS) with values of -6.65 kcal/mol, 0.57 Å and -5.98 kcal/mol, 1.05 Å, respectively. Conclusions: These findings suggest that benzo[de][1,6]-naphthyridine alkaloids from A. suberitoides can be good candidates as cholinesterase inhibitors.

Authors

Publication Details

Journal
Journal of Pharmacy & Pharmacognosy Research
Published
2024-12-18
DOI
https://doi.org/10.56499/jppres24.2064_13.3.757
Citations
1
Primary Topic
Cholinesterase and Neurodegenerative Diseases
Type
article
Field-Weighted Citation Impact
0.45
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In vitro and in silico cholinesterase inhibitory activities of aaptamine and derivatives from Aaptos suberitoides

Kuan Hung Ong, I Wayan Mudianta, Nitra Nuengchamnong, Suciati Suciati et al.
1 citations
Journal of Pharmacy & Pharmacognosy Research
Cholinesterase and Neurodegenerative Diseases
0.45
article

In vitro and in silico cholinesterase inhibitory activities of aaptamine and derivatives from Aaptos suberitoides

Kuan Hung Ong, I Wayan Mudianta, Nitra Nuengchamnong, Suciati Suciati, Kishneth Palaniveloo, Mary Ann George, Mohammed Rizman‐Idid, Nungruthai Suphrom, Edwin Setiawan, Aty Widyawaruyanti, Rhesi Kristiana, Hanifa Rahma Putri
article en
1 citations

Abstract

Context: Marine sponges from the genus Aaptos produce compounds, often alkaloids, with a wide range of bioactivities. Aaptos suberitoides exhibits anticancer, antioxidant, antibacterial proteasome inhibitory, and receptor activator of NF-kappaB ligand (RANKL) inhibitory activities. Alkaloids from marine sponges have shown potency as cholinesterase inhibitors, one of the targets in Alzheimer’s disease treatment. Aims: To isolate, identify, and investigate the potency of alkaloids from the water fraction of marine sponge A. suberitoides as cholinesterase inhibitors. Methods: Bioassay-guided isolation was employed to obtain active alkaloids. The cholinesterase inhibitory assay was conducted based on Ellman’s method with slight modification. Identification of isolated compounds was carried out based on NMR and MS data. The identified compounds were also subjected to molecular docking analysis as well as an ADMET study. Results: Bioassay-guided isolation of water fraction yielded aaptamine (1) and a mixture containing five benzo[de][1,6]-naphthyridine derivatives, identified based on NMR and LC-MS/MS spectroscopy. Aaptamine (1) inhibited both acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) with IC50 values of 0.23 and 1.38 µg/mL, respectively. Likewise, the benzo[de][1,6]-naphthyridine mixture of N-demethylaaptanone (2), aaptanone (3), demethylaaptamine (4), aaptosine (5) and 8,9,9-trimethoxy-9H-benzo[de][1,6]-naphthyridine (6) recorded IC50 values of 0.39 and 1.61 µg/mL, respectively. Computational molecular docking analysis calculated the S-score and RMSD values of aaptamine (1) to be the best compared to galantamine for both AChE (PBD: 4EY6) and BChE (PDB: 4BDS) with values of -6.65 kcal/mol, 0.57 Å and -5.98 kcal/mol, 1.05 Å, respectively. Conclusions: These findings suggest that benzo[de][1,6]-naphthyridine alkaloids from A. suberitoides can be good candidates as cholinesterase inhibitors.

Journal of Pharmacy & Pharmacognosy ResearchVol. 13(5)
Openalex Percentile: Top 29%
Cholinesterase and Neurodegenerative Diseases
0.45
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.